KATHLEEN ANTHONE: Open Payments
NPI 1407539208 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 16 payments from 8 companies in 2025. Trend: 2023 $20 · 2024 $564 · 2025 $461
Food & beverage: $362Education: $99
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 1 | $99 |
| ABBVIE INC. | 4 | $97 |
| Caris MPI, Inc. | 2 | $62 |
| Eisai Inc. | 3 | $58 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Fennec Pharmaceuticals, Inc. | 1 | $34 |
| GlaxoSmithKline, LLC. | 1 | $23 |
Products named: Enhertu, ELAHERE, MI CANCER SEEK, Lenvima, LYNPARZA, Fyarro, KEYTRUDA, JEMPERLI.
Industry payments across NE — which companies pay providers there.
